HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.

13th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2026

October 19 -21, 2026 | Boston, Massachusetts, USA
INBC 2026

Walk and dexa test predicts T2DM by appendicular right lateralisation loss

Speaker at Brain Disorders Conference - Seema Tewari
King George’s Medical College, India
Title : Walk and dexa test predicts T2DM by appendicular right lateralisation loss

Abstract:

Background: T2DM causes sarcopenia is a well-known condition now. Sarcopenia is being assessed by DXA and WALK test. We have
assessed in our study that whether left cerebral dominance is hampered in T2DM and are we able to diagnose it via DXA and WALK test.
Aims/Study Design: DXA and walk test is done in T2DM and compared with normal person of similar age groups to predict loss of left cerebral dominance.
Materials and Methods: DXA and WALK test is used to compare Lean Muscle Mass (Sarcopenic Diabetic vs. Normal), Comparison of Grip Strength, Comparison of Gait Speed, to calculate and correlate the Arm Lean (L/R) vs. Grip Strength, Comparison of Android vs. Gynoid Lean Distribution in T2DM patients (n = 22) with history more than 5 years with mean HBA1C of 7.5 and compared with normal persons (n = 22).
Results: Many combinations were compared and corelated with each other of T2DM and normal person. Statistically significant correlations

were seen of right leg, right grip strength when compared with right side and also with normal subjects.
Conclusions: In T2DM, Loss of right appendicular lateralisation (left cerebral dominance) as indicated by DEXA and walk test can predict left cerebral dysfunction in near future but fMRI may give a better prospective and objectivity with excellent corelation between these tests.

Keywords: Dexa; T2DM; Walk Tests; Left Cerebral Dominance

Biography:

Will be Updated Soon...

Watsapp